The Patent Finder

Andrx Labs, LLC

Also on record
Records under this name other than patents Andrx Labs, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Andrx Labs, LLC

PatentTitleStatus Expires Confidence
US 7,959,946Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,084,058Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Formerly held
Term ended
Term ended Aug 26, 2026 · From the USPTO record
Term endedTerm ended Aug 26, 2026From the USPTO record
US 7,785,627Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Formerly held
Term ended
Term ended Jul 31, 2026 · From the USPTO record
Term endedTerm ended Jul 31, 2026From the USPTO record
US 9,060,941Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Formerly held
Term ended
Ended no later than Mar 11, 2025 · Low confidence
Term endedEnded no later than Mar 11, 2025Low confidence
US 8,778,395Diltiazem controlled release formulation and method of manufacture
Lapsed on the fee record
Ended Jul 15, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jul 15, 2022From the USPTO record
US 6,866,866Controlled release metformin compositions
Formerly held
Term ended
Term ended Apr 14, 2021 · From the USPTO record
Term endedTerm ended Apr 14, 2021From the USPTO record
US 6,790,459Methods for treating diabetes via administration of controlled release metformin
Formerly held
Term ended
Term ended Mar 17, 2021 · From the USPTO record
Term endedTerm ended Mar 17, 2021From the USPTO record
US D536,246Packaging unit
Formerly held
Term ended
Term ended Feb 6, 2021 · From the USPTO record
Term endedTerm ended Feb 6, 2021From the USPTO record
US 8,679,534HMG-CoA reductase inhibitor extended release formulation
Formerly held
Term ended
Term ended Mar 26, 2020 · From the USPTO record
Term endedTerm ended Mar 26, 2020From the USPTO record
US 7,919,116Controlled release metformin formulations
Term ended
Term ended Oct 2, 2018 · From the USPTO record
Term endedTerm ended Oct 2, 2018From the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited